These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8749529

  • 1. [Combined hepatocellular and cholangiocarcinoma].
    Omagari K, Makiyama K, Ikuno N.
    Ryoikibetsu Shokogun Shirizu; 1995; (7):473-5. PubMed ID: 8749529
    [No Abstract] [Full Text] [Related]

  • 2. Hepatobiliary tumours.
    Simcock R.
    Practitioner; 2001 Aug; 245(1625):668-74. PubMed ID: 11524939
    [No Abstract] [Full Text] [Related]

  • 3. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
    Maeda Y, Nishida M, Mori N, Tamesa T, Okada T, Tangoku A, Oka M.
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():401-5. PubMed ID: 11761981
    [No Abstract] [Full Text] [Related]

  • 4. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
    Topaloğlu S, Sağlam K, Çalık A, Cobanoğlu Ü, Öztürk MH.
    Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684
    [Abstract] [Full Text] [Related]

  • 5. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N.
    J Hepatobiliary Pancreat Surg; 2006 Apr; 13(6):537-42. PubMed ID: 17139428
    [Abstract] [Full Text] [Related]

  • 6. [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Chen Y, Wang ZM, Ren ZG, Le F, Zhang BH, Xia JL, Ye SL, Tang ZY.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):299-300. PubMed ID: 16635306
    [No Abstract] [Full Text] [Related]

  • 7. Management of combined hepatocellular and cholangiocarcinoma.
    Kassahun WT, Hauss J.
    Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
    [Abstract] [Full Text] [Related]

  • 8. Combined hepatocellular and cholangiocellular carcinoma.
    Murakami T, Kim T, Tomoda K, Narumi Y, Sakon M, Wakasa K, Nakamura H.
    Radiat Med; 1997 Aug; 15(4):243-6. PubMed ID: 9311042
    [Abstract] [Full Text] [Related]

  • 9. A 46-Year-Old Asian Woman With Liver Mass.
    Morris GJ, Covey AM, D'Angelica M, Chang DT, Yen Y, Kelley RK, Greenberg H, Tsioulias G.
    Semin Oncol; 2015 Oct; 42(5):e67-76. PubMed ID: 26433558
    [No Abstract] [Full Text] [Related]

  • 10. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
    Hayashi H, Beppu T, Ishiko T, Mizumoto T, Masuda T, Okabe K, Baba Y, Okabe H, Takamori H, Kanemitsu K, Hiroto M, Baba H.
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153
    [Abstract] [Full Text] [Related]

  • 11. Mixed hepatocellular carcinoma and cholangiocarcinoma treated by extended left hepatic lobectomy with resection of the right hepatic vein and preservation of the inferior right hepatic vein after hepatic arterial infusion chemotherapy.
    Hanazaki K, Fujimori Y, Kajikawa S, Nakata S, Shimozawa N, Adachi W, Amano J.
    Hepatogastroenterology; 1998 Nov; 45(21):812-5. PubMed ID: 9684139
    [Abstract] [Full Text] [Related]

  • 12. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Kim JO, Jun DW, Jang K.
    Korean J Gastroenterol; 2013 Aug 25; 62(2):135-9. PubMed ID: 24133714
    [No Abstract] [Full Text] [Related]

  • 13. The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults.
    Verslype C, Libbrecht L.
    Best Pract Res Clin Gastroenterol; 2007 Aug 25; 21(6):983-96. PubMed ID: 18070699
    [Abstract] [Full Text] [Related]

  • 14. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I, Tannapfel A.
    Zentralbl Chir; 2007 Aug 25; 132(4):300-5. PubMed ID: 17724632
    [Abstract] [Full Text] [Related]

  • 15. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
    Uenishi T, Hirohashi K, Shuto T, Tsukamoto T, Yamamoto T, Kubo S, Tanaka H, Kinoshita H.
    Hepatogastroenterology; 2002 Aug 25; 49(46):1083-6. PubMed ID: 12143207
    [Abstract] [Full Text] [Related]

  • 16. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec 25; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic approach to hepatocellular carcinoma: a difficult choice.
    Gennari L.
    Ann Ital Chir; 2008 Dec 25; 79(2):79-80. PubMed ID: 18727268
    [Abstract] [Full Text] [Related]

  • 18. [Hepatology 2008].
    Thimme R, Spangenberg HC, Blum HE.
    Dtsch Med Wochenschr; 2008 Jun 25; 133(25-26):1366-9. PubMed ID: 18553264
    [No Abstract] [Full Text] [Related]

  • 19. [What can be done for patients with cancer of the digestive tract in 2003? Guidelines of the Francophone Federation of Digestive Tract Cancerology--part II].
    Conseil Scientifique de La FFCD.
    Gastroenterol Clin Biol; 2003 Jan 25; 27(1):43-58. PubMed ID: 12594364
    [No Abstract] [Full Text] [Related]

  • 20. [Liver adenoma and hepatobiliary cystadenoma].
    Takahama T, Kanai F, Onishi K.
    Ryoikibetsu Shokogun Shirizu; 1995 Jan 25; (7):387-91. PubMed ID: 8749503
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.